Get the free NDA 200-796 for Azilsartan Medoxomil (TAK491) IR Tablets - accessdata fda
Show details
This document provides a detailed review of the clinical pharmacology, biopharmaceutics, and associated study findings for Azilsartan Medoxomil, an angiotensin II receptor blocker proposed for the
We are not affiliated with any brand or entity on this form
Get, Create, Make and Sign nda 200-796 for azilsartan
Edit your nda 200-796 for azilsartan form online
Type text, complete fillable fields, insert images, highlight or blackout data for discretion, add comments, and more.
Add your legally-binding signature
Draw or type your signature, upload a signature image, or capture it with your digital camera.
Share your form instantly
Email, fax, or share your nda 200-796 for azilsartan form via URL. You can also download, print, or export forms to your preferred cloud storage service.
How to edit nda 200-796 for azilsartan online
To use our professional PDF editor, follow these steps:
1
Log in to account. Click on Start Free Trial and register a profile if you don't have one yet.
2
Prepare a file. Use the Add New button to start a new project. Then, using your device, upload your file to the system by importing it from internal mail, the cloud, or adding its URL.
3
Edit nda 200-796 for azilsartan. Rearrange and rotate pages, insert new and alter existing texts, add new objects, and take advantage of other helpful tools. Click Done to apply changes and return to your Dashboard. Go to the Documents tab to access merging, splitting, locking, or unlocking functions.
4
Save your file. Choose it from the list of records. Then, shift the pointer to the right toolbar and select one of the several exporting methods: save it in multiple formats, download it as a PDF, email it, or save it to the cloud.
It's easier to work with documents with pdfFiller than you could have believed. You may try it out for yourself by signing up for an account.
Uncompromising security for your PDF editing and eSignature needs
Your private information is safe with pdfFiller. We employ end-to-end encryption, secure cloud storage, and advanced access control to protect your documents and maintain regulatory compliance.
How to fill out nda 200-796 for azilsartan
How to fill out NDA 200-796 for Azilsartan Medoxomil (TAK491) IR Tablets
01
Gather necessary information about Azilsartan Medoxomil (TAK491) IR Tablets.
02
Complete the application form, providing details such as drug formulation, dosage, and indications.
03
Include all relevant preclinical and clinical study data supporting the safety and efficacy of the drug.
04
Prepare a summary of the drug's manufacturing process, including quality control measures.
05
Attach labeling and packaging information that complies with FDA regulations.
06
Review all sections for accuracy and completeness before submission.
07
Submit the NDA application through the FDA's electronic submission system.
Who needs NDA 200-796 for Azilsartan Medoxomil (TAK491) IR Tablets?
01
Pharmaceutical companies seeking approval to market Azilsartan Medoxomil (TAK491) IR Tablets.
02
Investors and stakeholders in the pharmaceutical industry interested in the drug’s market entry.
03
Healthcare providers looking for approved medications for hypertension management.
Fill
form
: Try Risk Free
People Also Ask about
Is Edarbi a good blood pressure medicine?
Take it as directed on the prescription label at the same time every day. You can take it with or without food. If it upsets your stomach, take it with food. Keep taking it unless your care team tells you to stop.
How much does azilsartan cost?
EDARBI Controls Blood Pressure Better Than Similar Medications. When scientists compared EDARBI with other medicines used to lower blood pressure, Benicar® (olmesartan) and Diovan® (valsartan), for 6 weeks, they found that EDARBI lowered blood pressure better.
Who should not take azilsartan?
tell your doctor if you have or have ever had heart failure, or kidney or liver disease. tell your doctor if you are breastfeeding. you should know that azilsartan may cause dizziness, lightheadedness, and fainting when you get up too quickly from a lying position.
What is the drug azilsartan medoxomil used for?
Azilsartan medoxomil is indicated for the treatment of hypertension to lower blood pressure in patients over 18 years of age. It may be used either alone or in combination with other antihypertensive agents. Some antihypertensive drugs have lesser effects on blood pressure in black patients.
What class of drug is azilsartan?
Azilsartan is a medication used in the management and treatment of hypertension. It is in the angiotensin-receptor blocking (ARB) class of drugs.
Does azilsartan affect the kidneys?
Congestive heart failure, severe—Use may lead to kidney problems.
When is the best time to take azilsartan?
Take it as directed on the prescription label at the same time every day. You can take it with or without food. If it upsets your stomach, take it with food. Keep taking it unless your care team tells you to stop.
For pdfFiller’s FAQs
Below is a list of the most common customer questions. If you can’t find an answer to your question, please don’t hesitate to reach out to us.
What is NDA 200-796 for Azilsartan Medoxomil (TAK491) IR Tablets?
NDA 200-796 is a New Drug Application submitted to the FDA for the approval of Azilsartan Medoxomil (TAK491) in its immediate-release (IR) tablet formulation, which is used to treat hypertension.
Who is required to file NDA 200-796 for Azilsartan Medoxomil (TAK491) IR Tablets?
The manufacturer or sponsor of Azilsartan Medoxomil (TAK491) is required to file NDA 200-796 to obtain approval for marketing the drug.
How to fill out NDA 200-796 for Azilsartan Medoxomil (TAK491) IR Tablets?
To fill out NDA 200-796, the applicant must provide detailed information on the drug's chemistry, manufacturing processes, preclinical and clinical trial data, labeling, and proposed use, following the FDA's guidelines.
What is the purpose of NDA 200-796 for Azilsartan Medoxomil (TAK491) IR Tablets?
The purpose of NDA 200-796 is to seek FDA approval for Azilsartan Medoxomil (TAK491) IR Tablets to ensure the drug's safety and efficacy for treating patients with hypertension.
What information must be reported on NDA 200-796 for Azilsartan Medoxomil (TAK491) IR Tablets?
NDA 200-796 must report information such as drug composition, manufacturing details, clinical study results, labeling information, and proposed indication for use.
Fill out your nda 200-796 for azilsartan online with pdfFiller!
pdfFiller is an end-to-end solution for managing, creating, and editing documents and forms in the cloud. Save time and hassle by preparing your tax forms online.
Nda 200-796 For Azilsartan is not the form you're looking for?Search for another form here.
Relevant keywords
Related Forms
If you believe that this page should be taken down, please follow our DMCA take down process
here
.
This form may include fields for payment information. Data entered in these fields is not covered by PCI DSS compliance.
